在两个病例中,带有eosinophilia的血管淋巴细胞增生症对dupilumab反应良好
Yi Jiang1,2,3, Yu Xiao1,2,3, Yang Wang1,2,3
1Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
The Journal of dermatological treatment
|April 14, 2025
概括
杜皮卢马布在治疗带有埃索诺菲利亚 (ALHE) 的血管淋巴状增生症,一种罕见的皮肤疾病方面表现有前途. 这种治疗提供了持续的反应和有利的安全性,为ALHE患者提供了新的治疗途径.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 血管淋巴状增生症与好色素 (ALHE) 是一种罕见的良性血管扩散性皮肤疾病.
- 目前用于ALHE的治疗方法的疗效低于最佳,复发率高.
- 新出现的证据表明ALHE涉及2型炎症和T细胞参与.
研究的目的:
- 调查dupilumab在治疗ALHE中的疗效和安全性.
- 探索2型炎症在ALHE病变发生中的作用.
主要方法:
- 两个ALHE患者 (65岁男性,27岁女性) 的案例研究.
- 用dupilumab进行治疗,dupilumab是一种IL-4受体α-对抗剂.
- 监测治疗反应和安全概况.
主要成果:
- 两位患者都通过dupilumab获得了持续的临床改善.
- 男患者在2个月内显著改善,治疗后3个月没有复发.
- 这位女性患者经历了结节的减少,并忍受了7个月的治疗,没有复发.
结论:
- 这些发现支持ALHE中2型炎症的假设.
- 这些结果突出了T细胞在ALHE病变发生过程中的关键作用.
- 杜皮卢马布为ALHE提供了一个有前途的治疗选择,可能与其他T辅助细胞类型2向治疗一起使用.
相关概念视频
Allergic Reactions
27.2K
Overview
27.2K
Allergic Drug Reactions
792
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
792
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
174
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
174
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


